Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ARCH Venture Partners
Biotech
Tenvie takes off with $200M, assets and exec from Denali
Tenvie has unveiled with $200 million and the goal of transforming neurological treatments, nabbing several programs from Denali Therapeutics.
Gabrielle Masson
Jan 8, 2025 8:00am
City Tx breaks ground with $135M, blueprints from Maraganore
Oct 8, 2024 10:38am
Arch closes $3B-plus fund to foster biopharma upstarts
Sep 26, 2024 10:24am
Metsera GLP-1 data slice reveals 7.5% weight loss at 36 days
Sep 24, 2024 7:00am
ArsenalBio raises $325M, pivots away from former lead asset
Sep 4, 2024 8:00am
Bob Nelsen on megarounds, Altos and psychedelics
May 1, 2024 10:56am